Embol
Embol, officially known as Embol S.A., is a leading player in the biotechnology industry, headquartered in Bolivia (BO). Founded in 2005, the company has established itself as a pioneer in the development of innovative medical solutions, particularly in the fields of vascular and interventional therapies. With a strong operational presence across South America, Embol focuses on producing high-quality embolic agents and medical devices that cater to the needs of healthcare professionals. Their unique offerings, such as advanced embolisation products, are designed to enhance patient outcomes and streamline clinical procedures. Recognised for its commitment to research and development, Embol has achieved significant milestones, positioning itself as a trusted name in the medical sector. The company continues to expand its market reach, driven by a dedication to innovation and excellence in patient care.
DitchCarbon Score
How does Embol's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Embol's score of 20 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Embol's reported carbon emissions
In 2021, Embol (Embotelladoras Bolivianas Unidas S.A.) reported significant carbon emissions, totalling approximately 62,441,068,000 kg CO2e for Scope 1, about 59,160,965,232 kg CO2e for Scope 2, and around 947,000 kg CO2e for Scope 3 emissions. This data reflects their global impact in the food and beverage processing sector. Embol has committed to achieving net-zero emissions by 2050, with a long-term target that encompasses all scopes of emissions. This commitment aligns with the Science Based Targets initiative (SBTi), which they joined in November 2021. Their efforts are part of a broader strategy to reduce their carbon footprint and contribute to climate action. The company has shown a trend of decreasing emissions from 2019 to 2021, with Scope 1 emissions dropping from approximately 52,260,638,000 kg CO2e in 2019 to 62,441,068,000 kg CO2e in 2021, and Scope 2 emissions decreasing from about 76,290,719,392,000 kg CO2e in 2019 to 59,160,965,232 kg CO2e in 2021. These reductions indicate a proactive approach to managing their environmental impact. Overall, Embol's climate commitments and emissions data reflect a serious dedication to sustainability and reducing their carbon footprint in the coming decades.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | |
|---|---|---|---|
| Scope 1 | 52,260,638,000 | 00,000,000,000 | 00,000,000,000 |
| Scope 2 | 76,290,719,392,000.02 | 00,000,000,000,000.00 | 00,000,000,000,000.00 |
| Scope 3 | 1,460,000 | 0,000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Embol is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
